Literature DB >> 34714976

Weight loss in primary care: A pooled analysis of two pragmatic cluster-randomized trials.

Peter T Katzmarzyk1, John W Apolzan1, Byron Gajewski2, William D Johnson1, Corby K Martin1, Robert L Newton1, Michael G Perri3, Jeffrey J VanWormer4, Christie A Befort5.   

Abstract

OBJECTIVE: The aim of this study was to report the results of five weight-loss interventions in primary care settings in underserved patients and to compare the level of pragmatism across the interventions using the Pragmatic Explanatory Continuum Indicator Summary (PRECIS-2) tool.
METHODS: Data from 54 primary care clinics (2,210 patients) were pooled from the Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL) and Rural Engagement in Primary Care for Optimizing Weight Reduction (REPOWER) cluster-randomized trials. Clinics were randomized to one of five comparators: PROPEL usual care, PROPEL combination of in-clinic and telephone visits, REPOWER in-clinic individual visits, REPOWER in-clinic group visits, or REPOWER telephone group visits.
RESULTS: At 24 months, weight loss (kilograms) was -0.50 (95% CI: -1.77 to 0.76), -3.05 (-4.10 to -2.01), -4.30 (-5.35 to -3.26), -4.79 (-5.83 to -3.75), and -4.80 (-5.96 to -3.64) in the PROPEL usual care, REPOWER in-clinic individual visits, REPOWER telephone group visits, REPOWER in-clinic group visits, and PROPEL in-clinic and telephone visits arms, respectively. At 24 months, percentage of weight loss was -0.360 (-1.60 to 0.88), -3.00 (-4.02 to -1.98), -4.23 (-5.25 to -3.20), -4.67 (-5.69 to -3.65), and -4.69 (-5.82 to -3.56), respectively, in the five arms. The REPOWER in-clinic individual visits intervention was the most pragmatic and reflects the current Centers for Medicare and Medicaid Services funding model, although this intervention produced the least weight loss.
CONCLUSIONS: Clinically significant weight loss over 6 months in primary care settings is achievable using a variety of lifestyle-based treatment approaches. Longer-term weight-loss maintenance is more difficult to achieve.
© 2021 The Obesity Society.

Entities:  

Mesh:

Year:  2021        PMID: 34714976      PMCID: PMC9520994          DOI: 10.1002/oby.23292

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   9.298


  27 in total

1.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

Authors:  Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristics.

Authors:  Peter T Katzmarzyk; Corby K Martin; Robert L Newton; John W Apolzan; Connie L Arnold; Terry C Davis; Kara D Denstel; Emily F Mire; Tina K Thethi; Phillip J Brantley; William D Johnson; Vivian Fonseca; Jonathan Gugel; Kathleen B Kennedy; Carl J Lavie; Eboni G Price-Haywood; Daniel F Sarpong; Benjamin Springgate
Journal:  Contemp Clin Trials       Date:  2018-02-08       Impact factor: 2.226

3.  Uptake of the centers for medicare and medicaid obesity benefit: 2012-2013.

Authors:  John A Batsis; Julie P W Bynum
Journal:  Obesity (Silver Spring)       Date:  2016-07-28       Impact factor: 5.002

4.  Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.

Authors:  Craig M Hales; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  NCHS Data Brief       Date:  2020-02

5.  Hospitalization and Mortality among Black Patients and White Patients with Covid-19.

Authors:  Eboni G Price-Haywood; Jeffrey Burton; Daniel Fort; Leonardo Seoane
Journal:  N Engl J Med       Date:  2020-05-27       Impact factor: 91.245

6.  Consort 2010 statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Gilda Piaggio; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2012-09-04

Review 7.  Managing obesity in primary care practice: a narrative review.

Authors:  Raymond Carvajal; Thomas A Wadden; Adam G Tsai; Katherine Peck; Caroline H Moran
Journal:  Ann N Y Acad Sci       Date:  2013-01-16       Impact factor: 5.691

Review 8.  The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.

Authors:  Daphne P Guh; Wei Zhang; Nick Bansback; Zubin Amarsi; C Laird Birmingham; Aslam H Anis
Journal:  BMC Public Health       Date:  2009-03-25       Impact factor: 3.295

9.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.

Authors:  Marshall Godwin; Lucia Ruhland; Ian Casson; Susan MacDonald; Dianne Delva; Richard Birtwhistle; Miu Lam; Rachelle Seguin
Journal:  BMC Med Res Methodol       Date:  2003-12-22       Impact factor: 4.615

10.  Obesity in patients with COVID-19: a systematic review and meta-analysis.

Authors:  Yi Huang; Yao Lu; Yan-Mei Huang; Min Wang; Wei Ling; Yi Sui; Hai-Lu Zhao
Journal:  Metabolism       Date:  2020-09-28       Impact factor: 8.694

View more
  1 in total

1.  Comparison of weight loss data collected by research technicians versus electronic medical records: the PROPEL trial.

Authors:  Peter T Katzmarzyk; Emily F Mire; Corby K Martin; Robert L Newton; John W Apolzan; Eboni G Price-Haywood; Kara D Denstel; Ronald Horswell; San T Chu; William D Johnson
Journal:  Int J Obes (Lond)       Date:  2022-05-06       Impact factor: 5.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.